A detailed history of Hantz Financial Services, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 21,768 shares of TEVA stock, worth $553,124. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,768
Previous 6,138 254.64%
Holding current value
$553,124
Previous $103,000 327.18%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$15.38 - $20.2 $240,389 - $315,726
15,630 Added 254.64%
21,768 $440,000
Q2 2025

Aug 04, 2025

BUY
$12.82 - $18.15 $73,266 - $103,727
5,715 Added 1351.06%
6,138 $103,000
Q1 2025

May 12, 2025

BUY
$14.67 - $22.01 $6,205 - $9,310
423 New
423 $7,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.